Legend Biotech CorporationLEGNNASDAQ
LOADING
|||
PE Ratio: Premium Valuation
Trending lower, above historical average.
Left:
||||
Price-to-earnings ratio
Latest
-16.81
↑ 72% above average
Average (7y)
-59.76
Historical baseline
Range
High:260.77
Low:-664.51
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -16.81 | -64.4% |
| 2023 | -10.22 | -14.9% |
| 2022 | -8.89 | -9.3% |
| 2021 | -8.13 | -30.2% |
| 2020 | -6.25 | +74.0% |
| 2019 | -24.04 | +96.4% |
| 2018 | -664.51 | -354.8% |
| 2017 | 260.77 | - |